Belangrijke publicaties uit de Medische
Oncologie 2006-2014
1. de Boer M, van Deurzen CH, van Dijck JA, Borm
GF, van Diest PJ, Adang EM, Nortier JW, Rutgers
EJ, Seynaeve C, Menke-Pluymers MB, Bult P, TjanWerkgroepleiders Medische Oncologie
1982-1993 professor dr. G.H. Blijham
Heijnen VC. Micrometastases or isolated tumor cells
and the outcome of breast cancer. New Engl J Med
2009;361:653-663.
1993-1996 professor dr. H.F.P. Hillen
1996-2003 professor dr. J. Wagstaff
2003-
professor dr. V.C. Tjan-Heijnen
2. de Boer M, van Dijck JAAM, Bult P, Borm GF,
Tjan-Heijnen VC. Breast cancer prognosis and occult
lymph node metastases, isolated tumor cells,
and micrometastases. J Natl Cancer Inst
2010;102:410-425.
3. Paulis Y, Soetekouw PMMB, Verheul HM,
Tjan-Heijnen VC, Griffioen A. Signalling pathways
in vasculogenic mimicry. Biochim Biophys Acta
2010;1806:18-28.
4. de Hoon JP, Veeck J, Vriens BE, Calon TG, van
Engeland M, Tjan-Heijnen VC. Taxane resistance
in breast cancer: A closed HER2 circuit?
BBA – Reviews on Cancer 2012;1825:197-206.
5. Aarts MJ, Peters FP, Mandigers CM, Dercksen
MW, Stouthard JM, Nortier HJ, van Laarhoven HW,
van Warmerdam LJ, van de Wouw AJ, Jacobs EM,
Mattijssen V, van der Rijt CC, Smilde TJ, van der
Velden AW, Temizkan M, Batman E, Muller EW, van
Gastel SM, Borm GF, Tjan-Heijnen VC. Primary
Granulocyte Colony-Stimulating Factor Prophylaxis
During the First Two Cycles Only or Throughout
All Chemotherapy Cycles in Patients With Breast
Cancer at Risk for Febrile Neutropenia. J Clin Oncol
2013;31:4290-6.
143
| Fabiënne Smeets | Machiel Smid | Marjanne Smook | Sobczak-Janssen | Patricia Soetekouw | Yvonne Soethoudt | L de Somer | A Sonnenberg | Yolanda Soons | Bart Spaetgens |